NLRP1 and Alzheimer disease: Aβ and other abnormally aggregated proteins can induce the NLRP1-mediated activation of interleukin-1β (IL-1β) and IL-18, which promote the maturation and secretion of inflammatory factors to participate in the inflammatory response and represent a new mechanism underlying the pathogenesis of AD, which is “pyroptosis” (9–11).